McMullen, Michelle
Karakasis, Katherine
Rottapel, Robert
Oza, Amit M.
Article History
First Online: 13 January 2021
Competing interests
: A.M.O. declares grants to his institution from AstraZeneca, outside the submitted work, and membership on uncompensated steering committees with AstraZeneca and Clovis and uncompensated advisory role with AstraZeneca and GSK. A.M.O. is principal investigator on investigator-initiated trials with agents from AstraZeneca, GSK and Clovis.